{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:45:00Z","timestamp":1761896700263,"version":"build-2065373602"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>We present a rare case of a 2-month-old girl, born at term, who was admitted to the pediatric intensive care unit for fussiness, increasing abdominal distension, and intermittent diarrhea for one week. She was found to be hypertensive, coagulopathic, and suffering from unrelenting ascites. Over the course of the following month, her symptoms became life-threatening, and she was intubated, sedated, and paralyzed. She underwent multiple diagnostic and therapeutic procedures, including exploratory laparotomy, MRI, colonoscopy, and multiple peritoneal drains. After several weeks, the medical teams reached a consensus diagnosis of a rare and complex vascular anomaly characterized by a life-threatening Kasabach\u2013Merritt Phenomenon (KMP). KMP is known to occur in association with several anomalies, including kaposiform hemangioendothelioma and kaposiform lymphangiomatosis. Life-saving therapies were initiated, including methylprednisolone and sirolimus. The patient was ultimately discharged and sent home with her parents. To our knowledge, this is the only reported case describing this constellation of symptoms in a critically ill infant. Multidisciplinary cooperation was key in saving the patient's life. Critical care providers should consider vascular anomalies in patients with similar presentations.<\/jats:p>","DOI":"10.3389\/fped.2025.1690450","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:25:27Z","timestamp":1761891927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Life-threatening Kasabach\u2013Merritt phenomenon in a 2-month-old child"],"prefix":"10.3389","volume":"13","author":[{"given":"Ashley V.","family":"Wong Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Forero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan M.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanwaljeet J. S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"B1","article-title":"Kasabach-Merritt syndrome. [Updated 2023 Jul 17]","volume-title":"StatPearls [Internet]","author":"Lewis","year":"2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.pcl.2010.07.006","article-title":"Kasabach-Merritt phenomenon","volume":"57","author":"Kelly","year":"2010","journal-title":"Pediatr Clin N Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MPH.0b013e3181a71830","article-title":"Kasabach-Merritt phenomenon: case series and retrospective review of the mayo clinic experience","volume":"31","author":"Rodriguez","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/pbc.25278","article-title":"Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder","volume":"62","author":"Fernandes","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","article-title":"Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals","volume":"162","author":"Croteau","year":"2013","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MPG.0000000000001209","article-title":"Ascites in children: a single-center experience of 27 years","volume":"64","author":"Karnsakul","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B7","first-page":"S2","article-title":"The epidemiology of infant cancers","author":"Birch","year":"1992","journal-title":"Br J Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10456-016-9537-2","article-title":"Angiopoietins as serum biomarkers for lymphatic anomalies","volume":"20","author":"Le Cras","year":"2017","journal-title":"Angiogenesis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/pbc.22766","article-title":"Treatment of childhood kaposiform hemangioendothelioma with sirolimus","volume":"55","author":"Blatt","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13023-020-01595-2","article-title":"Chronic lymphedema in patients with kaposiform hemangioendothelioma: incidence, clinical features, risk factors and management","volume":"15","author":"Ji","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-020-1320-1","article-title":"Kaposiform hemangioendothelioma: current knowledge and future perspectives","volume":"15","author":"Ji","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jpeds.2013.03.080","article-title":"Consensus-derived practice standards plan for complicated kaposiform hemangioendothelioma","volume":"163","author":"Drolet","year":"2013","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/lrb.2007.1012","article-title":"Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo","volume":"5","author":"Shirazi","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13023-019-1147-9","article-title":"Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences","volume":"14","author":"Ji","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/pbc.25422","article-title":"Successful treatment of kaposiform lymphangiomatosis with sirolimus","volume":"62","author":"Wang","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000478-199304000-00001","article-title":"Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis","volume":"17","author":"Zukerberg","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1097\/PAS.0000000000001898","article-title":"Kaposiform lymphangiomatosis: pathologic aspects in 43 patients","volume":"46","author":"Perez-Atayde","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/bjd.16601","article-title":"Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon","volume":"179","author":"Ji","year":"2018","journal-title":"Br J Dermatol"},{"key":"B21","first-page":"13711","article-title":"Clinicopathological features of kaposiform hemangioendothelioma","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41436-018-0390-0","article-title":"A somatic activating NRAS variant associated with kaposiform lymphangiomatosis","volume":"21","author":"Barclay","year":"2019","journal-title":"Genet Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1690450\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:25:30Z","timestamp":1761891930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1690450\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":22,"alternative-id":["10.3389\/fped.2025.1690450"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1690450","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1690450"}}